Your browser doesn't support javascript.
loading
Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.
Baron, Rebecca M; Kwon, Min-Young; Castano, Ana P; Ghanta, Sailaja; Riascos-Bernal, Dario F; Lopez-Guzman, Silvia; Macias, Alvaro Andres; Ith, Bonna; Schissel, Scott L; Lederer, James A; Reeves, Raymond; Yet, Shaw-Fang; Layne, Matthew D; Liu, Xiaoli; Perrella, Mark A.
Afiliação
  • Baron RM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kwon MY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Castano AP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Ghanta S; Department of Pediatric Newborn Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Riascos-Bernal DF; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Lopez-Guzman S; Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Macias AA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Ith B; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Schissel SL; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Lederer JA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Reeves R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Yet SF; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Layne MD; Department of Chemistry, School of Molecular Biosciences, Institute of Biological Chemistry, Washington State University, Pullman, Washington, USA.
  • Liu X; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
  • Perrella MA; Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA.
J Leukoc Biol ; 104(4): 677-689, 2018 10.
Article em En | MEDLINE | ID: mdl-29975792
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Sepse / Proteína HMGA1a Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Sepse / Proteína HMGA1a Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article